MENU × BUSINESS
Banking And InsuranceCryptocurrencyDigital MarketingErpFood And BeveragesHealthcareLegalMarketing And AdvertisingMedia And EntertainmentMetals And MiningOil And GasRetailTelecom
TECHNOLOGY
Artificial IntelligenceBig DataCloudCyber SecurityE CommerceEducationGaming And VfxIT ServiceMobileNetworkingSAPScience And TechnologySecuritySoftwareStorage
PLATFORM
CiscoDatabaseGoogleIBMJuniperM2MMicrosoftOracleOracleRed Hat
LEADERSHIP
CEO ReviewCompany Review
MAGAZINE
ASIA INDIA
STARTUPS CLIENT SPEAK CONTACT US

The Silicon Review Asia

E-commerce companies battling over online pharma retail business

E-commerce companies battling over online pharma retail business

As online pharma retail industries are flourishing unexpectedly, it has become the next big thing in the online retail business. All the big e-commerce giants including Amazon, Flipkart, BigBasket etc. are reportedly in talks to acquire, invest or partner in online pharma retailers to build a high-frequency play in India. Some of the online pharma companies in consideration for this are MedPlus, 1mg, Medlife, PharmEasy etc.

The online medicine delivery system is something in which all the big e-commerce players want to invest as it is a golden opportunity to expand their businesses given easy regulation in pharma retail sector, and profitable business as it involves repeat order from same customers. The interest in this sector has increased since the Indian Government has issued a draft policy for regulating the sector.

According to the sources, Medlife, run by a pharmaceutical company Alkem Labs, is in discussions with Amazon as well as Flipkart. Medplus is also a strong contender for this because of its network of 1,400 stores across India as well as its dominance in online delivery business.

Big basket and Swiggy are also looking to diversify their business and hence planning to partner with e-pharmacies to enter into medicine delivery as well. As all the discussions are in the preliminary stage, companies are denying to comment on it. “We may think of talking for financial investments at this stage. Acquisition is not on the cards”, said Dharmil Sheth, CEO of PharmEasy. Prashant Tandon, CEO of 1mg denies such conversations. Although it is too soon for companies to confirm the news, we can still expect tough competition in this sector soon!

YOU MAY ALSO LIKE

Tariff plans will cost higher from the next financial year as telecom companies are gearing up to increase rates

The ongoing Covid pandemic had significantly increased the number of mobile and internet users worldwide. The high amount of usage is expected to drop...

Business Travelers to Stay at Singapore’s Changi Airport Bubble

Singapore’s open economy depends heavily on tourism and business. But its vibrant but small economy has been hurting as the circumstances due to...

Countries in Asia-Pacific are marching towards ‘green recovery’ amidst Covid-19 crisis

2020 has been an unforgettable year for many of us. The ongoing Covid crisis has reminded people that it is very important to have an uninterrupted an...

Department of Telecommunication to announce the new schedule for 5G trials

Department of Telecommunications (DoT) is all set to announce the new schedule for 5G trials. The Dot made this decision after being pulled by the par...

RECOMMENDED